Overview

Spinal Cord Injury Neuroprotection With Glyburide

Status:
Terminated
Trial end date:
2021-02-08
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety of using oral Glyburide in patients with acute traumatic cervical spinal cord injuries (SCI).
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Ohio State University
Treatments:
Glyburide